AL-3152
| Code | Size | Price |
|---|
| TAR-T29814-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
AL-3152 is a bio-active chemical.
CAS:
126048-33-7
Formula:
C16H10F2N2O3
Molecular Weight:
316.264
Purity:
0.98
SMILES:
COc1cc(F)cc2c1-c1ccc(F)cc1[C@@]21NC(=O)NC1=O
References
1. Robison WG Jr, Laver NM, Jacot JL, Chandler ML, York BM, Glover JP. Efficacy of treatment after measurable diabeticlike retinopathy in galactose-fed rats. Invest Ophthalmol Vis Sci. 1997 May;38(6):1066-73. PubMed PMID: 9152226.
2. Park YH, Mayer PR, Barker R, DuPriest M, Griffin BW, Williams GW, York BM, Slattery JT. Comparison of the pharmacokinetics and pharmacodynamics of the aldose reductase inhibitors, AL03152 (RS), AL03802 (R), and AL03803 (S). Pharm Res. 1993 Apr;10(4):593-7. PubMed PMID: 8483844.
3. Kiss AD, Haggard K, Veltman JC, Ziegler DM. Oxidation of aldose reductase inhibitors ALO-4114 and ALO-3152 catalyzed by liver microsomes. Drug Metab Dispos. 1992 Nov-Dec;20(6):948-53. PubMed PMID: 1362951.
4. Chien JY, Banfield CR, Brazzell RK, Mayer PR, Slattery JT. Saturable tissue binding and imirestat pharmacokinetics in rats. Pharm Res. 1992 Apr;9(4):469-73. PubMed PMID: 1495891.